News

Biocon, Wockhardt, Eris to double insulin output, as global drugmakers scale back to focus on GLP-1, new generation insulins
Human insulin presents Indian companies an opportunity estimated at Rs 450 crore per annum in India and $157 million/annum in ...
The ‘golden dose’ of Mounjaro that experts warn could be deadly – as slimmers rave about it saving money
A GROWING number of slimmers are trying to squeeze extra jabs out of empty Mounjaro pens in a risky bid to cut costs. The ...
Contract Pharma22h
Lilly Licenses Camurus’ FluidCrystal Technology for Long-Acting GLP-1s
Camurus and Lilly have entered a collaboration and license agreement, granting Lilly exclusive, worldwide rights to the ...